Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation

Genes and Immunity

Volumn 13, Issue 7, 2012, Pages 515-522

  Munthe Fog, L ^a   Hummelshoj, T ^a   Honore C ^a   Moller, M E ^a   Skjoedt, M O ^a   Palsgaard, I ^a   Borregaard, N ^a   Madsen, H O ^a   Garred, P ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

complement lectin pathway; FCN1; Ficolin 1; inflammation; innate immunity; monocyte

Indexed keywords

FICOLIN; FICOLIN 1; GELATINASE; PROTEIN A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COMPLEMENT LECTIN PATHWAY; CROSS REACTION; FATALITY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRANULOCYTE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENE FREQUENCY; HOMOZYGOTE; HUMANS; LECTINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RNA, MESSENGER; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84867745038     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.27     Document Type: Article

References (39)

1. Endo Y, Matsushita M, Fujita T. The role of ficolins in the lectin pathway of innate immunity. Int J Biochem Cell Biol 2011; 43: 705-712.
2. Garred P, Honoré C, Ma YJ, Rørvig S, Cowland J, Borregaard N et al. The genetics of ficolins. J Innate Immun 2010; 2: 3-16.
3. Hummelshoj T, Thielens NM, Madsen HO, Arlaud GJ, Sim RB, Garred P et al. Molecular organization of human Ficolin-2. Mol Immunol 2007; 44: 401-411.
4. Sugimoto R, Yae Y, Akaiwa M, Kitajima S, Shibata Y, Sato H et al. Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J Biol Chem 1998; 273: 20721-20727.
5. Ohashi T, Erickson HP. Oligomeric structure and tissue distribution of ficolins from mouse, pig and human. Arch Biochem Biophys 1998; 360: 223-232.
6. Kuraya M, Ming Z, Liu X, Matsushita M, Fujita T. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology 2005; 209: 689-697.
7. Jensen ML, Honoré C, Hummelshøj T, Hansen BE, Madsen HO, Garred P et al. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 2007; 44: 856-865.
8. Honore C, Hummelshoj T, Hansen BE, Madsen HO, Eggleton P, Garred P et al. The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum 2007; 56: 1598-1607.
9. Gout E, Garlatti V, Smith DF, Lacroix M, Dumestre-Pérard C, Lunardi T et al. Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin. J Biol Chem 2010; 285: 6612-6622.
10. Honore C., Rørvig S, Munthe-Fog L, Hummelshøj T, Madsen HO, Borregaard N et al. The innate pattern recognition molecule Ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma. Mol Immunol 2008; 45: 2782-2789.
11. Hummelshoj T, Fog LM, Madsen HO, Sim RB, Garred P. Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). Mol Immunol 2008; 45: 1623-1632.
12. Kilpatrick DC, Fujita T, Matsushita M. P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients. Immunol Lett 1999; 67: 109-112.
13. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, Garred P et al. Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet 2005; 14: 1651-1658.
14. Munthe-Fog L, Hummelshøj T, Hansen BE, Koch C, Madsen HO, Skjødt K et al. The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol 2007; 65: 383-392.
15. Akaiwa M, Yae Y, Sugimoto R, Suzuki SO, Iwaki T, Izuhara K et al. Hakata antigen, a new member of the ficolin/opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and bile. J Histochem Cytochem 1999; 47: 777-786.
16. Lu J, Le Y, Kon OL, Chan J, Lee SH. Biosynthesis of human ficolin, an Escherichia coli-binding protein, by monocytes: comparison with the synthesis of two macrophage-specific proteins, C1q and the mannose receptor. Immunology 1996; 89: 289-294.
17. Teh C, Le Y, Lee SH, Lu J. M-ficolin is expressed on monocytes and is a lectin binding to N-acetyl-D-glucosamine and mediates monocyte adhesion and phagocytosis of Escherichia coli. Immunology 2000; 101: 225-232.
18. Liu Y, Endo Y, Iwaki D, Nakata M, Matsushita M, Wada I et al. Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol 2005; 175: 3150-3156.
19. Honore C, Rørvig S, Hummelshøj T, Skjoedt MO, Borregaard N, Garred P et al. Tethering of Ficolin-1 to cell surfaces through recognition of sialic acid by the fibrinogen-like domain. J Leukoc Biol 2010; 88: 145-158.
20. Endo Y, Sato Y, Matsushita M, Fujita T. Cloning and characterization of the human lectin P35 gene and its related gene. Genomics 1996; 36: 515-521.
21. Rorvig S, Honore C, Larsson LI, Ohlsson S, Pedersen CC, Jacobsen LC et al. Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP. J Leukoc Biol 2009; 86: 1439-1449.
22. Kakinuma Y, Endo Y, Takahashi M, Nakata M, Matsushita M, Takenoshita S et al. Molecular cloning and characterization of novel ficolins from Xenopus laevis. Immunogenetics 2003; 55: 29-37.
23. Hummelshoj T, Munthe-Fog L, Madsen HO, Garred P. Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns. Mol Immunol 2008; 45: 2508-2520.
24. Kjeldsen L, Bjerrum OW, Hovgaard D, Johnsen AH, Sehested M, Borregaard N et al. Human neutrophil gelatinase: a marker for circulating blood neutrophils. Purification and quantitation by enzyme linked immunosorbent assay. Eur J Haematol 1992; 49: 180-191.
25. Kjeldsen L, Koch C, Arnljots K, Borregaard N. Characterization of two ELISAs for NGAL, a newly described lipocalin in human neutrophils. J Immunol Methods 1996; 198: 155-164.
26. Vander Cruyssen B. et al. Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis. Rheumatology (Oxford) 2007; 46: 1792-1795.
27. Ye J, Young HA, Ortaldo JR, Ghosh P. Identification of a DNA binding site for the nuclear factor YY1 in the human GM-CSF core promoter. Nucleic Acids Res 1994; 22: 5672-5678.
28. Wittenborn T, Thiel S, Jensen L, Nielsen HJ, Jensenius JC. Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun 2010; 2: 167-180.
29. Kjaer TR, Hansen AG, Sørensen UB, Nielsen O, Thiel S, Jensenius JC et al. Investigations on the pattern recognition molecule M-ficolin: quantitative aspects of bacterial binding and leukocyte association. J Leukoc Biol 2011; 90: 425-437.
30. Munthe-Fog L, Hummelshøj T, Ma YJ, Hansen BE, Koch C, Madsen HO et al. Characterization of a polymorphism in the coding sequence of FCN3 resulting in a ficolin-3 (Hakata antigen) deficiency state. Mol Immunol 2008; 45: 2660-2666.
31. Schlapbach LJ, Thiel S, Aebi C, Hirt A, Leibundgut K, Jensenius JC et al. M-ficolin in children with cancer. Immunobiology 2011; 216: 633-638.
32. Frederiksen PD, Thiel S, Larsen CB, Jensenius JC. M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand J Immunol 2005; 62: 462-473.
33. Garred P, Strom J, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003; 188: 1394-1403.
34. Kirschfink M. Controlling the complement system in inflammation. Immuno-pharmacology 1997; 38: 51-62.
35. Ward PA, Gao H. Sepsis, complement and the dysregulated inflammatory response. J Cell Mol Med 2009; 13: 4154-4160.
36. Kornblit B, Munthe-Fog L, Madsen HO, Strøm J, Vindeløv L, Garred P et al. Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit Care 2008; 12: R83.
37. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992; 268: 3452-3455.
38. Reading CL. Theory and methods for immunization in culture and monoclonal antibody production. J Immunol Methods 1982; 53: 261-291.
39. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97-98.